Ian Karp
Public Communications Contact chez INTELLIA THERAPEUTICS, INC.
Postes actifs de Ian Karp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - | - |
Historique de carrière de Ian Karp
Anciens postes connus de Ian Karp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHIRE | Investor Relations Contact | 01/03/2016 | 01/12/2017 |
| Corporate Officer/Principal | 01/01/2012 | 01/01/2016 | |
| Medimmune, Inc. | Sales & Marketing | - | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | 25/07/2018 | - |
| Public Communications Contact | 25/07/2018 | - |
Formation de Ian Karp
| Emory University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
| Irlande | 2 |
Opérationnelle
| Investor Relations Contact | 2 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Medimmune, Inc. | Health Technology |
